論文

国際誌
2022年8月

Different patterns of sensory nerve involvement in chronic inflammatory demyelinating polyneuropathy subtypes.

Muscle & nerve
  • Kazumoto Shibuya
  • Atsuko Tsuneyama
  • Sonoko Misawa
  • Yo-Ichi Suzuki
  • Tomoki Suichi
  • Yuta Kojima
  • Keigo Nakamura
  • Hiroki Kano
  • Ryo Ohtani
  • Yuya Aotsuka
  • Marie Morooka
  • Mario Prado
  • Satoshi Kuwabara
  • 全て表示

66
2
開始ページ
131
終了ページ
135
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1002/mus.27530

INTRODUCTION/AIMS: Among subtypes of chronic inflammatory demyelinating polyneuropathy (CIDP), different immune pathophysiologies have been proposed. In this study, sensory nerve conduction studies were compared among clinical subtypes to attempt to better understand the underlying pathophysiology. METHODS: A total of 138 patients with CIDP was classified into clinical subtypes: typical CIDP (N = 68), multifocal CIDP (N = 27), or other (N = 2). Patients with immunoglobulin M (IgM) neuropathy anti-myelin-associated glycoprotein neuropathy (MAG; N = 19) were also included as disease controls. Sensory nerve action potentials (SNAPs) were recorded in the median, ulnar, and superficial radial and sural nerves. RESULTS: SNAP amplitudes (P < .05) and conduction velocities (P < .01) in the median nerve and conduction velocities (P < .05) in the ulnar nerve were lower in typical CIDP than in multifocal CIDP, whereas those in the radial and sural nerves were comparable in each group. Low median and normal sural SNAP amplitudes were more common in typical CIDP (P < .005) than in multifocal CIDP, suggesting predominant involvement at terminal portions of the nerves. DISCUSSION: Terminal portions of sensory nerves are preferentially affected in typical CIDP compared with multifocal CIDP. These findings might be partially explained by the hypothesis of antibody-mediated demyelination in typical CIDP at the regions where the blood-nerve barrier is anatomically deficient, whereas multifocal CIDP predominantly affects the nerve trunks, largely due to cell-mediated demyelination, with disruption of the blood-nerve barrier.

リンク情報
DOI
https://doi.org/10.1002/mus.27530
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/35307862
ID情報
  • DOI : 10.1002/mus.27530
  • PubMed ID : 35307862

エクスポート
BibTeX RIS